Annual Cash & Cash Equivalents
$6.78 M
+$1.35 M+24.84%
31 December 2023
Summary:
STRATA Skin Sciences annual cash & cash equivalents is currently $6.78 million, with the most recent change of +$1.35 million (+24.84%) on 31 December 2023. During the last 3 years, it has fallen by -$3.82 million (-36.02%). SSKN annual cash & cash equivalents is now -77.77% below its all-time high of $30.52 million, reached on 31 December 2010.SSKN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$7.06 M
+$1.58 M+28.80%
30 September 2024
Summary:
STRATA Skin Sciences quarterly cash and cash equivalents is currently $7.06 million, with the most recent change of +$1.58 million (+28.80%) on 30 September 2024. Over the past year, it has dropped by -$69.00 thousand (-0.97%). SSKN quarterly cash and cash equivalents is now -80.25% below its all-time high of $35.76 million, reached on 30 September 2010.SSKN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SSKN Cash And Cash Equivalents Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +24.8% | -1.0% |
3 y3 years | -36.0% | -45.9% |
5 y5 years | -58.9% | -56.5% |
SSKN Cash And Cash Equivalents High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -46.1% | +24.8% | -45.9% | +150.0% |
5 y | 5 years | -58.9% | +24.8% | -56.5% | +150.0% |
alltime | all time | -77.8% | +6141.0% | -80.3% | +6396.8% |
STRATA Skin Sciences Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $7.06 M(+28.8%) |
June 2024 | - | $5.48 M(+4.7%) |
Mar 2024 | - | $5.24 M(-22.8%) |
Dec 2023 | $6.78 M(+24.8%) | $6.78 M(-4.9%) |
Sept 2023 | - | $7.13 M(-21.1%) |
June 2023 | - | $9.03 M(+219.8%) |
Mar 2023 | - | $2.83 M(-48.0%) |
Dec 2022 | $5.43 M(-56.8%) | $5.43 M(-27.1%) |
Sept 2022 | - | $7.45 M(-25.7%) |
June 2022 | - | $10.04 M(-8.1%) |
Mar 2022 | - | $10.92 M(-13.2%) |
Dec 2021 | $12.59 M(+18.7%) | $12.59 M(-3.5%) |
Sept 2021 | - | $13.05 M(+36.2%) |
June 2021 | - | $9.58 M(-4.7%) |
Mar 2021 | - | $10.04 M(-5.3%) |
Dec 2020 | $10.60 M(+30.4%) | $10.60 M(-4.1%) |
Sept 2020 | - | $11.06 M(-1.5%) |
June 2020 | - | $11.23 M(+37.8%) |
Mar 2020 | - | $8.15 M(+0.3%) |
Dec 2019 | $8.13 M(-50.7%) | $8.13 M(-49.9%) |
Sept 2019 | - | $16.23 M(+1.8%) |
June 2019 | - | $15.94 M(-2.7%) |
Mar 2019 | - | $16.39 M(-0.6%) |
Dec 2018 | $16.49 M(+305.2%) | $16.49 M(+3.8%) |
Sept 2018 | - | $15.89 M(+10.0%) |
June 2018 | - | $14.45 M(+322.7%) |
Mar 2018 | - | $3.42 M(-16.0%) |
Dec 2017 | $4.07 M(+3.6%) | $4.07 M(+30.1%) |
Sept 2017 | - | $3.13 M(-20.6%) |
June 2017 | - | $3.94 M(+4.7%) |
Mar 2017 | - | $3.76 M(-4.2%) |
Dec 2016 | $3.93 M(+18.9%) | $3.93 M(+32.8%) |
Sept 2016 | - | $2.96 M(+4.1%) |
June 2016 | - | $2.84 M(-8.9%) |
Mar 2016 | - | $3.12 M(-5.5%) |
Dec 2015 | $3.30 M(-71.1%) | $3.30 M(+4.2%) |
Sept 2015 | - | $3.17 M(-42.9%) |
June 2015 | - | $5.55 M(-32.6%) |
Mar 2015 | - | $8.23 M(-28.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2014 | $11.43 M(+202.2%) | $11.43 M(-21.0%) |
Sept 2014 | - | $14.47 M(+244.2%) |
June 2014 | - | $4.20 M(-48.3%) |
Mar 2014 | - | $8.12 M(+114.7%) |
Dec 2013 | $3.78 M(-51.9%) | $3.78 M(+44.4%) |
Sept 2013 | - | $2.62 M(-82.7%) |
June 2013 | - | $15.15 M(-30.0%) |
Mar 2013 | - | $21.65 M(+175.3%) |
Dec 2012 | $7.86 M(-71.9%) | $7.86 M(-40.8%) |
Sept 2012 | - | $13.28 M(-22.9%) |
June 2012 | - | $17.21 M(-22.8%) |
Mar 2012 | - | $22.30 M(-20.3%) |
Dec 2011 | $28.00 M(-8.3%) | $28.00 M(+64.7%) |
Sept 2011 | - | $17.00 M(-18.8%) |
June 2011 | - | $20.94 M(-19.6%) |
Mar 2011 | - | $26.04 M(-14.7%) |
Dec 2010 | $30.52 M(+2.9%) | $30.52 M(-14.6%) |
Sept 2010 | - | $35.76 M(+41.2%) |
June 2010 | - | $25.31 M(-15.7%) |
Mar 2010 | - | $30.04 M(+1.2%) |
Dec 2009 | $29.67 M(+96.9%) | $29.67 M(+19.8%) |
Sept 2009 | - | $24.78 M(+219.9%) |
June 2009 | - | $7.75 M(-31.2%) |
Mar 2009 | - | $11.25 M(-25.3%) |
Dec 2008 | $15.07 M(-21.5%) | $15.07 M(-19.7%) |
Sept 2008 | - | $18.78 M(+59.6%) |
June 2008 | - | $11.76 M(-26.0%) |
Mar 2008 | - | $15.90 M(-17.2%) |
Dec 2007 | $19.20 M(-8.3%) | $19.20 M(-17.5%) |
Sept 2007 | - | $23.27 M(+54.4%) |
June 2007 | - | $15.08 M(-17.0%) |
Mar 2007 | - | $18.16 M(-13.3%) |
Dec 2006 | $20.94 M(+13.2%) | $20.94 M(+118.1%) |
Sept 2006 | - | $9.60 M(+46.8%) |
June 2006 | - | $6.54 M(-18.2%) |
Mar 2006 | - | $7.99 M(-56.8%) |
Dec 2005 | $18.50 M(>+9900.0%) | $18.50 M(+1275.0%) |
Sept 2005 | - | $1.35 M(+663.8%) |
June 2005 | - | $176.20 K(+62.1%) |
Dec 2004 | $108.70 K | $108.70 K |
FAQ
- What is STRATA Skin Sciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for STRATA Skin Sciences?
- What is STRATA Skin Sciences annual cash & cash equivalents year-on-year change?
- What is STRATA Skin Sciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for STRATA Skin Sciences?
- What is STRATA Skin Sciences quarterly cash and cash equivalents year-on-year change?
What is STRATA Skin Sciences annual cash & cash equivalents?
The current annual cash & cash equivalents of SSKN is $6.78 M
What is the all time high annual cash & cash equivalents for STRATA Skin Sciences?
STRATA Skin Sciences all-time high annual cash & cash equivalents is $30.52 M
What is STRATA Skin Sciences annual cash & cash equivalents year-on-year change?
Over the past year, SSKN annual cash & cash equivalents has changed by +$1.35 M (+24.84%)
What is STRATA Skin Sciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SSKN is $7.06 M
What is the all time high quarterly cash and cash equivalents for STRATA Skin Sciences?
STRATA Skin Sciences all-time high quarterly cash and cash equivalents is $35.76 M
What is STRATA Skin Sciences quarterly cash and cash equivalents year-on-year change?
Over the past year, SSKN quarterly cash and cash equivalents has changed by -$69.00 K (-0.97%)